- Growth failure due to growth hormone deficiency
HEADON 4 IU
| MRP | : |
|
| Price | : | ₹700.00 |
| You Save | : | ₹393.75 (36%) |
1 vial(s)
Headon 4IU injection, containing the active ingredient Somatropin, is a hormonal drug classified as a human growth hormone (hGH) agonist. Its primary use is to treat growth failure in children resulting from growth hormone deficiency, Turner’s syndrome, being small for gestational age, and short stature of unknown cause. Beyond addressing growth hormone deficiency, treatment with this medication also contributes to improved muscle mass, enhanced exercise capacity, increased bone mineral density, and a reduction in fat mass.
However, Headon 4IU injection is contraindicated in several conditions: severe obesity, acute critical illness, upper airway obstruction, sleep apnea, cancer, diabetes, impaired glucose tolerance, hypersensitivity to the drug, hypothyroidism, hypoadrenalism, scoliosis, and pancreatitis. It is crucial to contact your doctor immediately if you experience breathlessness, rapid heartbeat, a severe rash, swelling of the arms or legs, or any other anaphylactic reactions. During treatment with Headon 4IU injection, your doctor may periodically monitor various vital parameters, including your blood count, blood sugar, and thyroid function, to prevent serious complications.
You should report to your doctor if you have a history of diabetes, heart problems, hypothyroidism, pancreatitis, cancer, obesity, or acute illnesses. The effect of this drug on fertility is not known, so it is advisable to consult your doctor for more advice regarding this. Headon 4IU injection is not considered safe for use during pregnancy; therefore, report to your doctor if you are pregnant, suspect you might be pregnant, or are planning for pregnancy before initiating treatment. It is highly advised to use this injection with caution during breastfeeding.


